Elham Askari
ORCID: 0000-0003-3285-7028
· 3 papers in corpus
review
2025
article
2022
Objectives:This study aimed to assess the therapeutic effect of a dopamine agonist (bromocriptine) together with medroxyprogesterone for three months on ovarian endometrioma size. Materials and Methods: In this double-blind randomized clini…
review
2019
BACKGROUND: Endometriosis is seen in 0.5%-5% of fertile and 25%-40% of infertile women. To investigate this conflict between gynecologists that ovarian endometriomas should be removed or not before making any decision about pregnancy among …